NR1H4 and liver disorder: UDCA can facilitate liver disease treatment by activating the farnesoid X receptor (FXR)/FGF-15 signaling pathway, regulating apoptosis and autophagy, enhancing intestinal barrier function, and reducing the toxicity of microbe-associated molecular patterns (MAMPs) (Mao et al., 2024).